INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GE HealthCare Technologies Inc. - GEHC

NEW YORK CITY, NY / ACCESS Newswire / May 8, 2026 / Pomerantz LLP is investigating claims on behalf of investors of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ:GEHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether GE HealthCare and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. Among other items, GE HealthCare reported adjusted earnings per share of $0.99, missing the consensus estimate of $1.05, and cut its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00, down from prior guidance of $4.95 to $5.15. CEO Peter Arduini said that "[p]rofitability in the first quarter was impacted by a PDx supplier issue that has since been resolved."

On this news, GE HealthCare's stock price fell $9.02 per share, or 13.16%, to close at $59.49 per share on April 29, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

SOURCE: Pomerantz LLP